Beyond the diagnosis.
We focus on the complexities of cancer so you can focus on the care.
OncoHealth delivers digital health solutions that reduce the physical, mental, and financial toll of cancer for everyone involved.
How we can help:
The first digital telehealth platform for people with cancer.
Support before, during, and after cancer treatment.
OncoHealth is dedicated to helping health plans, employers, providers, patients, and life science researchers navigate the physical, mental and financial complexities of cancer through technology enabled services and real-world data.
Rebecca's StoryRebecca, a 61-year-old grandmother and substitute teacher was diagnosed with a rare form of inflammatory breast cancer, underwent chemotherapy and a modified radical mastectomy. A month after her surgery, Rebecca developed multiple lesions below her mastectomy scar which turned out to be metastatic breast cancer to the skin.
Medical Moment of TruthRebecca and her doctors faced a choice of between the molecularly targeted therapies Piqray or Ibrance, either in combination with letrozole. Her tumor’s next-generation sequencing biomarker data revealed a PIK3CA H1047R mutation, which suggested that Piqray could be an effective treatment. But Rebecca’s medical records described a history of poorly controlled diabetes, and Piqray is known to cause or worsen high blood sugar in many patients who take it.
Personalized TreatmentsRebecca’s health plan was presented with a request for treatment with Piqray + letrozole at a 3-month cost of $54,828. Given that Piqray-based therapy has only been proven effective in the second-line setting, OncoHealth reviewed the data and found that a first-line treatment of Ibrance + letrozole could reduce the risk of death by 34%, avoid the risk of potentially life-threatening hyperglycemia, and result in a 3-month savings of $14,397.
24x7 Supportive CareRebecca became consumed with worry about the future. She started making excuses about attending social events and she began to feel isolated. Her health plan mentioned a new support service they were offering to all members undergoing cancer treatment called Iris. She signed up and began talking with a peer mentor who had also experienced breast cancer in midlife.
Advancing Oncology ResearchLeveraging de-identified, real-world data from a cohort of patients like Rebecca, life sciences researchers were able to answer questions such as do certain cohorts have better outcomes with one drug versus another; what impact does a PIK3CA mutation have on treatment effectiveness, and why was one drug prescribed over another?
Trusted for Our Oncology Expertise by:
ASO Employers with over 250+ Employees
What’s New in Oncology Immunotherapy: Navigating the Complex Path Ahead
OncoHealth™ Unveils Real-World Evidence Dashboard for Pan Tumor, Immunotherapy Research
May 16, 2022
OncoHealth Secures Strategic Investments from Arsenal Capital Partners & McKesson Corporation
May 9, 2022
EY Names OncoHealth CEO Rick Dean As an Entrepreneur Of The Year® 2022 Southeast Award Finalist
May 5, 2022
Rapidly Changing Landscape of Biomarker-guided Checkpoint Inhibitors is Leading to More Tumor-Agnostic Indications
April 14, 2022
OncoHealth™ Launches New Consumer Platform Bringing Digital Telehealth Services to People with Cancer
OncoHealth Collaborates with Three Innovative Health Plans to Deliver Personalized Supportive Care
March 22, 2022
OncoHealth Named One of the Top Workplaces for 2022 by The Atlanta Journal-Constitution
March 14, 2022
OncoHealth and Triple-S Salud of Puerto Rico Partner for Evidence-Based Cancer Treatment
Digital Health Company Now Handling Oncology Treatment Reviews for 100% of Medicare Advantage and Medicaid Members
January 11, 2022